Utility of a newly developed Mueller-Hinton E agar for the detection of MRSA carrying the novel mecA homologue mecC
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:70 |
|---|---|
| Enthalten in: |
The journal of antimicrobial chemotherapy - 70(2015), 4, Seite 1256 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Larsen, Anders Rhod [VerfasserIn] |
|---|
| Links: |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1969064900 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1969064900 | ||
| 003 | DE-627 | ||
| 005 | 20220222033018.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC1969064900 | ||
| 035 | |a (DE-599)GBVOLC1969064900 | ||
| 035 | |a (PRQ)p834-344d566411e5a6790965acb8d2790ee732f6bad65d24aa66659da878bdc2f7a70 | ||
| 035 | |a (KEY)0114639420150000070000401256utilityofanewlydevelopedmuellerhintoneagarforthede | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 084 | |a 44.75 |2 bkl | ||
| 084 | |a 44.38 |2 bkl | ||
| 100 | 1 | |a Larsen, Anders Rhod |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Utility of a newly developed Mueller-Hinton E agar for the detection of MRSA carrying the novel mecA homologue mecC |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 650 | 4 | |a Bacteriological Techniques - methods | |
| 650 | 4 | |a Methicillin-Resistant Staphylococcus aureus - isolation & purification | |
| 650 | 4 | |a Cattle Diseases - microbiology | |
| 650 | 4 | |a Staphylococcal Infections - veterinary | |
| 650 | 4 | |a Culture Media - chemistry | |
| 650 | 4 | |a Staphylococcal Infections - microbiology | |
| 650 | 4 | |a Anti-Bacterial Agents - pharmacology | |
| 700 | 1 | |a Petersen, Andreas |4 oth | |
| 700 | 1 | |a Holmes, Mark |4 oth | |
| 700 | 1 | |a Kearns, Angela |4 oth | |
| 700 | 1 | |a Hill, Robert |4 oth | |
| 700 | 1 | |a Edwards, Giles |4 oth | |
| 700 | 1 | |a Teale, Christopher |4 oth | |
| 700 | 1 | |a Skov, Robert |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of antimicrobial chemotherapy |d Oxford : Oxford Univ. Press, 1975 |g 70(2015), 4, Seite 1256 |w (DE-627)129426873 |w (DE-600)191709-2 |w (DE-576)01480087X |x 0305-7453 |7 nnns |
| 773 | 1 | 8 | |g volume:70 |g year:2015 |g number:4 |g pages:1256 |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/25538168 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 936 | b | k | |a 44.75 |q AVZ |
| 936 | b | k | |a 44.38 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 70 |j 2015 |e 4 |h 1256 | ||